Limited data on human poisonings with cyanide salts suggest that hydroxocobalamin is an effective antidote Read more about the Functional Benefits of Hydrocobalamin 3
Liraglutide, semaglutide and tirzepatide are incretin-based therapies currently approved by FDA for the management of obesity, while triple GIPR/GCGR/GLP-1R agonist retatrutide (LY3437943), the cagrilintide/semaglutide (CagriSema) 2.4 mg combination, high-dose oral semaglutide, and oral orforglipron are in advanced stages of development
Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines
SARMs | Bone Health Neither SARMs nor peptides have been shown to reliably increase bone mass and bone mineral density (BMD) in human studies
Clinicians, patients, and researchers need to balance possible advantages with safety data gaps, product inconsistencies, and drug interactions before using them